$AME

AMETEK Posts Record Q3 Sales and Adjusted EPS, Raises 2026 Guidance

AMETEK reported Q3 2026 sales of $2.22B, up 17% YoY, and adjusted EPS of $2.21. GAAP EPS was $1.85, with net income at $426.3M. The company raised its full-year adjusted EPS outlook to $8.53–$8.57. Growth was driven by organic sales, acquisitions, and strong demand across its businesses. AMETEK also completed the acquisition of Indicor Instrumentation.

Original reporting
Published Nov 3, 2026, 3:33 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 3:39 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AMETEK Posts Record Q3 Sales and Adjusted EPS, Raises 2026 Guidance — source image
Decision brief

The 30-second read

$AMEBullishHigh
01

Why it matters

The raised full-year adjusted EPS outlook is the key decision input for traders, potentially shifting consensus and near-term positioning in AME and industrial peers.

02

Market read

A guidance raise tied to record quarterly performance is a direct catalyst for earnings estimate revisions and valuation repricing.

03

What to watch

The article highlights acquisitions and orders growth but does not quantify margin drivers or segment mix, which can be key for follow-through beyond the headline EPS range.

Relevance 9/10Novelty 9/10Timing: after-hours/market reaction window on the Nov. 3, 2026 earnings and guidance release

Background

AMETEK is reporting Q3 2026 results with record sales and adjusted EPS, and it also notes acquisition contribution during the quarter.

Company-level read

Ticker impact

$AMEBullishHigh confidence
Context

AMETEK reported record Q3 2026 sales and adjusted EPS, then raised full-year adjusted EPS guidance to $8.53–$8.57.

Expected impact

Likely upward bias as the market reprices full-year earnings expectations toward the raised adjusted EPS range.

Evidence & confidence

The article discloses fresh primary numbers (record Q3 and a higher full-year adjusted EPS outlook), which typically drive estimate revisions and valuation support.

Market effects

Signals strength in industrial instrumentation/electronics demand and may support sentiment for industrial automation and measurement peers.

Primarily US large-cap industrial sentiment; could modestly lift broader industrials exposure in US trading.

Limited direct global read-through, but multinational industrial demand strength can influence cross-border industrial positioning.

Counterpoint

Guidance raises may already be partially anticipated; investors may focus on whether organic orders growth can offset acquisition-related integration and any margin normalization risk.

Key entities

  • AMETEK

    Reported record Q3 2026 sales and adjusted EPS, raised full-year adjusted EPS guidance, and completed the Indicor Instrumentation acquisition during the quarter.

Related articles

$AMEHighAI 9/10

AMETEK Announces Record Third Quarter 2026 Results and Raises Full Year Guidance

AMETEK INC/ (AME) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 AMETEK Announces Record Third Quarter 2026 Results and Raises Full Year Guidance Berwyn, Pa., Nov 3, 2026 – AMETEK, Inc. (NYSE: AME) today announced its financial results for the third quarter ended September 30, 2026. AMETEK’s third quarter 2026 sales were a record

$AMEMedAI 9/10

AMETEK’s (NYSE:AME) Q3 2026 sales beat estimates

AMETEK reported Q3 2026 revenue of $2.22 billion, exceeding estimates by 2.9% and growing 17.3% year-on-year. Adjusted EPS was $2.21, beating estimates by 4.8%. Management raised full-year adjusted EPS guidance to $8.55 at the midpoint, a 3.6% increase. Operating margin remained steady at 26.3%, while free cash flow margin improved to 23.8% from 22.2% year-on-year.

$AMEMedAI 9/10

Ametek: Q3 Earnings Snapshot

Ametek Inc. (AME) reported Q3 net income of $426.3M, or $1.85 per share, beating estimates. Revenue was $2.22B, also surpassing forecasts. The company projects Q4 EPS of $2.26-$2.30 and full-year EPS of $8.53-$8.57. Shares are up 18% YTD and 20% over 12 months.